Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02088684
Title Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | GBR | FRA | ESP

Facility Status City State Zip Country Details
University of Alabama at Birmingham/ Kirklin Clinic Dept Onc Birmingham Alabama 35294-0006 United States Details
Dana Farber Cancer Institute Onc. Dept. Boston Massachusetts 02215 United States Details
Sarah Cannon Research Institute Onc Dept Nashville Tennessee 37203 United States Details
Novartis Investigative Site Lyon Cedex 69373 France Details
Novartis Investigative Site Milano MI 20132 Italy Details
Novartis Investigative Site Modena MO 41124 Italy Details
Novartis Investigative Site Seoul Korea 06351 Korea, Republic of Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Madrid 28050 Spain Details
Novartis Investigative Site Taipei Taiwan ROC 10041 Taiwan Details
Novartis Investigative Site Leicester LE1 5WW United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field